Business Description
Niki BioSolutions Inc. is a clinical-stage drug development company focused on finding new treatments for cancer and infectious diseases, including bacterial infections and coronavirus. The company is currently running early-stage clinical trials for several promising drug candidates targeting conditions such as neuroblastoma, tuberculosis, and drug-resistant staph infections. Founded in 2010 and based in Princeton, New Jersey, it operates as part of Jurchen Investment Corporation.
